A short-duration dark adaptation protocol for assessment of age-related maculopathy
- PMID: 20072631
- PMCID: PMC2802416
- DOI: 10.1007/s12177-008-9002-6
A short-duration dark adaptation protocol for assessment of age-related maculopathy
Abstract
Dark adaptometry may be a useful diagnostic test and clinical trial endpoint for age-related maculopathy (ARM) because impaired night vision is a hallmark of early ARM. A novel dark adaptometer, the AdaptDx, was evaluated for the detection of ARM. The AdaptDx incorporates a 20-minute protocol optimized for the detection of ARM. ARM patients (N = 17) exhibited substantial dark adaptation impairment compared with normal adults (N = 17). The diagnostic sensitivity was 88% and the specificity was 100%. The diagnostic test characteristics of the AdaptDx are similar to previously reported studies using 60- to 120-minute protocols.
Keywords: Age-related macular degeneration; Clinical trial endpoint; Dark adaptation; Diagnostic; Human; Macular degeneration.
Figures
References
-
- Curcio CA, Medeiros NE, Millican LC. Photoreceptor loss in age-related macular degeneration. Invest Ophthalmol Vis Sci. 1996;37(7):1236–1249. - PubMed
-
- Curcio CA, Millican CL. Basal linear deposit and large drusen are specific for early age-related maculopathy. Arch of Ophthalmol. 1999;117:329–339. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources